Evidence for safety and efficacy of risedronate in men with osteoporosis over 4years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study

Steven Boonen, Roman S. Lorenc, Dietrich Wenderoth, Karen J. Stoner, Rachelle Eusebio, Eric S. Orwoll

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Evidence for safety and efficacy of risedronate in men with osteoporosis over 4years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences